Wake Forest Baptist Comprehensive Cancer Center
- Research works
- 93 ▲ 841% vs 2013–17
- Citations
- 1.7k 18.3 per fractional work
- Top-10% rate
- 21.7% record average 16.5%
- Open access
- 67% world 28%
Not ranked overall: Wake Forest Baptist Comprehensive Cancer Center is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
- Medicine 3.5×
- Immunology and Microbiology 3.5×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Economics, Econometrics and Finance 1.3×
- Neuroscience 1.1×
- Health Professions 1.1×
- Psychology 0.5×
- Nursing 0.4×
- Mathematics 0.3×
- Social Sciences 0.2×
- Chemistry 0.2×
- Materials Science 0.1×
- Physics and Astronomy 0.1×
- Engineering 0.1×
- Decision Sciences 0.1×
- Environmental Science 0.0×
- Agricultural and Biological Sciences 0.0×
- Computer Science 0.0×
Which keywords describe research at Wake Forest Baptist Comprehensive Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Health-related Quality of Life, Prognostic Scoring System, JAK2 Mutation, Myelofibrosis, Cancer, Immunotherapy and Chemotherapy.
- Population-Based Study
- Cancer Treatment
- Ethical Considerations
- Cancer Incidence
- BCR-ABL
- Minimal Residual Disease
- Prognosis
- Radiotherapy
- Mutation
- Childhood Cancer Survivor Study
- AML
- Patient-Reported Outcomes
- Cancer Survivorship
- Hematopoietic Stem Cells
- Tumor Microenvironment
- Chemotherapy
- Immunotherapy
- JAK2 Mutation
- Health-related Quality of Life
- Cancer
- Inflammation
- Prognostic Factors
- Prognostic Scoring System
- Myelofibrosis
- Quality of Life
- Depression
- Aging
- Anxiety
- Physical Activity
- Psychosocial Interventions
- Acute Myeloid Leukemia
- Clinical Trials
- Pediatric Quality of Life Inventory
- Cancer Therapy
- Health Disparities
- Targeted Therapy
- Imatinib
- Elderly Patients
- Cancer Immunotherapy
- End-of-Life
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation4▲ 3.7×21 topics
- Cancer4▲ 5.6×18 topics
- Prognostic Factors4▲ 16×8 topics
- Health-related Quality of Life4▲ 29×2 topics
- Prognostic Scoring System4▲ 171×2 topics
- JAK2 Mutation3▲ 276×1 topic
- Myelofibrosis3▲ 276×1 topic
- Immunotherapy3▲ 8.5×13 topics
- Quality of Life3▲ 4.1×12 topics
- Chemotherapy3▲ 7.9×15 topics
- Depression2▲ 4.5×4 topics
- Tumor Microenvironment2▲ 9.0×6 topics
- Aging2▲ 7.0×4 topics
- Hematopoietic Stem Cells2▲ 44×3 topics
- Anxiety2▲ 7.9×3 topics
- Cancer Survivorship2▲ 51×2 topics
- Physical Activity2▲ 7.3×2 topics
- Patient-Reported Outcomes2▲ 65×1 topic
- Psychosocial Interventions2▲ 65×1 topic
- AML2▲ 65×1 topic
- Acute Myeloid Leukemia2▲ 65×1 topic
- Childhood Cancer Survivor Study2▲ 74×1 topic
- Clinical Trials2▲ 4.8×8 topics
- Mutation2▲ 17×4 topics
- Pediatric Quality of Life Inventory2▲ 74×1 topic
- Radiotherapy2▲ 7.9×8 topics
- Cancer Therapy2▲ 4.9×12 topics
- Prognosis2▲ 8.7×3 topics
- Health Disparities1▲ 10×4 topics
- Minimal Residual Disease1▲ 40×2 topics
- Targeted Therapy1▲ 12×4 topics
- BCR-ABL1▲ 95×1 topic
- Imatinib1▲ 95×1 topic
- Cancer Incidence1▲ 17×3 topics
- Elderly Patients1▲ 14×2 topics
- Ethical Considerations1▲ 6.8×3 topics
- Cancer Immunotherapy1▲ 14×3 topics
- Cancer Treatment1▲ 9.4×6 topics
- End-of-Life1▲ 24×1 topic
- Population-Based Study1▲ 34×2 topics
Which research topics does Wake Forest Baptist Comprehensive Cancer Center publish most on?
By volume in 2022–2025: Myeloproliferative Neoplasms: Diagnosis and Treatment, Cancer survivorship and care, Acute Myeloid Leukemia Research and Childhood Cancer Survivors' Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 3 works
- 2 Cancer survivorship and care Oncology 2 works
- 3 Acute Myeloid Leukemia Research Hematology 2 works
- 4 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 2 works
- 5 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 7 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 9 Global Cancer Incidence and Screening Oncology 1 works
- 10 Frailty in Older Adults Geriatrics and Gerontology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Wake Forest Baptist Comprehensive Cancer Center's research output changed?
Output in 2018–2022 was 841% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.